MENU

Fox Chase Cancer Center News

July 15, 2020

Fox Chase Cancer Center Welcomes Brandon Bachert

PHILADELPHIA (July 15, 2020) – Fox Chase Cancer Center announces the hiring of Brandon Bachert, MD, who will join the department of diagnostic imaging as a full time body imager. Bachert will be an assistant professor on the academic track.

July 14, 2020

Fox Chase Cancer Center Welcomes J. Nicholas Bodor

PHILADELPHIA (July 14, 2020) – J. Nicholas Bodor, MD, PhD, MPH, will join the Department of Hematology/Oncology and serve in the Thoracic Oncology Program upon completion of the Fox Chase-Temple Hematology/Oncology Fellowship Program.

July 13, 2020

Genome Profiling, Fox Chase Cancer Center to Collaborate on Immune System Blood Test to Predict Checkpoint Inhibitor Response in Non-Small Cell Lung Cancer

PHILADELPHIA (July 13, 2020) – Genome Profiling and Fox Chase Cancer Center will collaborate to identify a novel immune system epigenetic biomarker, dubbed EpiMarker, which if successful, will be used to help predict which lung cancer patients are likely to respond to a checkpoint inhibitor therapy known as anti-PD1 antibody. These agents are a potentially valuable tool for lung cancer treatment, but it remains very difficult for doctors to predict which patients are most likely to benefit from them.

“We’re dealing with lung cancer and our lung cancer patients may be more at risk for severe disease due to COVID-19. A lot of the management we do puts them at greater risk after that,” said Sameera Kumar, MD, one of the authors on the paper and an assistant professor in the Department of Radiation Oncology.
July 1, 2020

Fox Chase Researchers Help Identify Best Practices for Cancer Patient Care During COVID-19

PHILADELPHIA (July 1, 2020)—Researchers at Fox Chase Cancer Center were part of a national team that published a paper identifying best practices for facilities to protect vulnerable cancer patients during the COVID-19 pandemic.

Dr. J.K. Wong
July 1, 2020

Fox Chase Researchers Look at Toxicity, Outcomes in Determining Treatments for Older Patients With Rectal Cancer

PHILADELPHIA (July 1, 2020)—In a recent study, researchers at Fox Chase Cancer Center found that factors other than just age can be useful in determining courses of treatment for older patients with locally advanced rectal cancer.

Jeffrey M. Farma, MD, FACS, one of the study’s authors
June 29, 2020

Study by Fox Chase Researchers Indicates Gene Mutations From UV Exposure May Play Role in Melanoma Malignancy

PHILADELPHIA (June 29, 2020)—Researchers at Fox Chase Cancer Center recently conducted a study analyzing the impact of sun exposure and tanning patterns on gene mutations in patients with advanced melanoma. Those who experienced blistering sunburn had a higher number of gene mutations in their tumors compared to those who did not experience blistering sunburn.

June 25, 2020

Fox Chase Cancer Center’s Radiation Oncology Residency Program Receives Accreditation

PHILADELPHIA (June 25, 2020) – The Accreditation Council for Graduate Medical Education (ACGME) review committee stated that the program “demonstrated outstanding compliance with the ACGME’s Program Requirements and/or Institutional Requirements.” ACGME would not require a site visit for the next 10 years, the longest duration allowed by the ACGME.

Jeffrey Chang-Jen Liu, MD, FACS
June 25, 2020

Fox Chase Researchers Explore Racial Disparities in Survival for Head and Neck Cancer Patients

PHILADELPHIA (June 25, 2020)—Survival rates for Black patients were worse than those for white patients being treated for head and neck cancer even when they had access to the same care. The researchers said the disparities could be explained by biological differences between the two groups.

Pages

Connect with Fox Chase